Ampersand boosts efforts in high-tech cervical screening
This article was originally published in Clinica
Executive Summary
Cancer diagnosis company Ampersand Medical hopes to considerably improve its prospects as one of the small group of companies that are developing cervical cell collection technology with an automated screening system.